about
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situAn overview of the c-MET signaling pathwayGenetic targeting of the kinase activity of the Met receptor in cancer cellsTargeting RTK Signaling Pathways in CancerTargeted therapeutic strategies for the management of renal cell carcinomaRAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontinThe oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitorMelanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METAssessing the significance of chromosomal aberrations in cancer: methodology and application to gliomaMACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.Metastasis: a therapeutic target for cancer.The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.Host-pathogen systems biology: logical modelling of hepatocyte growth factor and Helicobacter pylori induced c-Met signal transductionExpression analysis of genes and pathways associated with liver metastases of the uveal melanoma.Systemic therapy for advanced hepatocellular carcinoma: an update.Quantitative analysis of three-dimensional human mammary epithelial tissue architecture reveals a role for tenascin-C in regulating c-met function.Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells.Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer modelsAnalysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review.17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cellsA U87-EGFRvIII cell-specific aptamer mediates small interfering RNA delivery.Synergistic signaling of tumor cell invasiveness by hepatocyte growth factor and hypoxia.Fibroblast heterogeneity in the cancer wound.Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathwaysThe genetic basis of kidney cancer: a metabolic diseaseSmall molecule c-Met kinase inhibitors: a review of recent patents.c-MET protects breast cancer cells from apoptosis induced by sodium butyrate.Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progressionmiR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.The target therapy of ovarian clear cell carcinoma.Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation.Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in MedulloblastomaConstitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met.Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor.Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors
P2860
Q21195234-8F9F9E6E-E6EA-4C01-A6BE-F518F04BFF6BQ24633986-C8E3F6EF-A410-473C-B321-47421F5B59B5Q24675200-42B2EBCA-9130-4080-B367-39B46C910B52Q26781278-9B281EBE-2AA7-4D20-A082-ABED1B136F24Q27013846-B7A642CE-356D-4082-A210-2B4D06E68DFBQ28568239-3AADD2AF-923A-42C4-A290-84D83CA46D5DQ28821187-5A91755A-CEE7-44F3-93FB-B466320D1B3DQ29618139-D80E304F-53C5-40CD-86F3-8F392B59730BQ30014823-58A0AF86-41AB-4F5A-AF61-69EFF89D86F5Q30157439-95B9F0BD-EAC2-477F-83D3-DACE0E8C1451Q30439221-28765F7A-7CCD-4C17-853F-B8C3FC3CD574Q30494514-3C4B1045-BEF9-43CB-823A-8EF61FBE4DCBQ33314672-34CFF513-18C6-4EFE-A43A-27D5A0FEB880Q33589266-E649BB60-D973-4504-8189-BBB8808E48BCQ33593213-7B3EAFBA-7233-47F1-BDDC-196E0DCFD4C3Q33597170-148B6E0B-CEBF-40AE-AA37-7287870735D5Q33604480-9A608BE8-C77E-46C4-868A-D5A1B54105FFQ33645135-94532F43-33BE-412F-9545-CB9FD47DCBD8Q33649756-183FFA6A-D90B-4647-BE62-B32497837F42Q33688498-CF12326B-C84F-43BC-9950-47F93CEB031EQ33733546-3E674A3F-23FA-43A2-AAED-BA7E25D14AE3Q33946966-1030E254-0DB6-4ACB-8C49-A3CC1F05EF34Q33964324-D955F51C-CD4B-46EA-AA37-30B282212C49Q34003880-FECD1D73-E31F-439F-BFE4-262C7CAA98A9Q34087148-BFC85EF7-8F37-475D-B879-D8A8FD2FEC12Q34094632-DF6C5B11-D23C-4E78-B286-ABA5C312AA8BQ34131128-05FE4E57-157C-4885-9F73-8CA9CF6F487AQ34135637-67A965E9-7978-4FB6-AF26-FD3E15130A36Q34194306-3CAD945D-CD51-41D1-AC73-704644A398E8Q34195513-D49E0015-2DC2-46D5-960B-231627B0278CQ34211970-5DBC6221-0E9E-496B-AE90-DC4AD384BB47Q34216877-38919563-1606-4DED-B797-8BA9F56DF3EAQ34274069-EB5EED50-F09B-4C55-B81A-D6604ABCF211Q34340834-B1774B33-095E-4769-9182-B5B39D0B2B8BQ34388854-0B50CA5D-23F6-4FBC-AECD-07029B43E0C9Q34398276-5BE4D2FB-EC77-47C5-885A-DF13C7163FC9Q34494731-904EDCD2-9416-4310-B69F-C119D08FC05EQ34755653-72C9988C-191F-419F-8C33-F983A856BBDBQ35051790-13B9420A-8121-4694-9D92-2402E0D8EF8AQ35053276-1C9C46AB-B80F-46DC-8F5C-0D1E8F6B52D8
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Targeting the c-Met signaling pathway in cancer
@ast
Targeting the c-Met signaling pathway in cancer
@en
Targeting the c-Met signaling pathway in cancer
@nl
type
label
Targeting the c-Met signaling pathway in cancer
@ast
Targeting the c-Met signaling pathway in cancer
@en
Targeting the c-Met signaling pathway in cancer
@nl
prefLabel
Targeting the c-Met signaling pathway in cancer
@ast
Targeting the c-Met signaling pathway in cancer
@en
Targeting the c-Met signaling pathway in cancer
@nl
P3181
P1476
Targeting the c-Met signaling pathway in cancer
@en
P2093
Benedetta Peruzzi
P304
P3181
P356
10.1158/1078-0432.CCR-06-0818
P407
P577
2006-06-01T00:00:00Z